Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1Hyperphagia 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 52Radiotherapy 43Cetuximab 30Fluorouracil 27pembrolizumab 19Carboplatin 19Docetaxel 14Paclitaxel 8Radiotherapy, Intensity-Modulated 7Nivolumab 6Methotrexate 6Drug Therapy 6Surgical Procedures, Operative 5Chemotherapy, Adjuvant 5Radiation 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4nimotuzumab 3Taxes 3Chemoradiotherapy 3toripalimab 2lenvatinib 2epacadostat 2durvalumab 2dehydroftorafur 2camrelizumab 2avelumab 2advexin 2Specimen Handling 2Radiotherapy, Conformal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Squamous Cell Carcinoma of Head and Neck × Emulsions × Clear all
NCT02236936 2020-05-01

AGMT_HNO_PN

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Terminated
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Hyperphagia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡